報價延遲最少15分鐘:2025/09/18 05:44 EDT
盤前時段
|
||||
|
-- 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
126.72
|
|
|
| 價值評估 |
|
盈利(現時/預測)
4.28/6.04
|
|
企業價值
39.40B
|
| 資產負債 |
|
每股賬面淨值
22.47
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
6.51B
|
|
每股收益
24.67
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/09/18 05:44 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations. |
